Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 86,283 shares at $10.75 ($937K) on 2019-12-26, disclosed to the SEC on 2020-01-03.
Seasonal sale ($937k) by Chief Operating Officer — this insider has traded STML in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.58 | 4,319 | $46K | 4.9% |
| 2 | $10.97 | 24,477 | $269K | 28.7% |
| 3 | $10.97 | 24,477 | $269K | 28.7% |
| 4 | $10.75 | 15,494 | $167K | 17.8% |
| 5 | $10.75 | 15,494 | $167K | 17.8% |
| 6 | $10.48 | 2,022 |
| $21K |
| 2.3% |
| Total | $10.86 avg | 86,283 | $937K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |